# OnCo record nct05382442 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05382442/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05382442", "NCT05382442" ;
  schema:name "A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer"@en ;
  schema:description "A phase 2 trial of Ivonescimab, AK117, CAPOX in colorectal cancer, run by Akeso, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05382442/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05382442> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-06-27" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/ivonescimab/>, <https://onco.cc/drugs/ak117/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/flot/> ;
  onco:companies <https://onco.cc/companies/akeso/> .